Skip to Content
VirusesViruses
  • Review
  • Open Access

6 November 2022

14 Pages

The Impact of the COVID-19 Pandemic on Otitis Media

,
,
,
,
,
,
,
and
1
Department of Otorhinolaryngology Head & Neck Surgery, Kyung Hee University School of Medicine, Kyung Hee University Medical Center, Seoul 02447, Korea
2
Center for Digital Health, Medical Science Research Institute, Kyung Hee University School of Medicine, Kyung Hee University Medical Center, Seoul 02447, Korea
3
Department of Pediatrics, Kyung Hee University School of Medicine, Kyung Hee University Medical Center, Seoul 02447, Korea
4
Department of Biomedical Engineering, Kyung Hee University, Yongin 17104, Korea
This article belongs to the Special Issue Pediatric Respiratory Viral Infection

Abstract

Otitis media is one of the most common diseases in children, with 80% of children experiencing it by the age of three years. Therefore, the resulting social burden is enormous. In addition, many countries still suffer from complications due to otitis media. Meanwhile, COVID-19 has affected many diseases, with otitis media being one of the most strongly affected. This review aims to find out how COVID-19 has affected otitis media and its significance. A series of measures brought about by COVID-19, including emphasis on personal hygiene and social distancing, had many unexpected positive effects on otitis media. These can be broadly classified into four categories: first, the incidence of otitis media was drastically reduced. Second, antibiotic prescriptions for otitis media decreased. Third, the incidence of complications of otitis media was reduced. Fourth, the number of patients visiting the emergency room due to otitis media decreased. The quarantine measures put in place due to COVID-19 suppressed the onset and exacerbation of otitis media. This has great implications for the treatment and prevention of otitis media.

1. Introduction

Otitis media (OM) is a group of complex infectious and inflammatory conditions affecting the middle ear, and various subtypes differ in their presentation, associated complications, and treatment. OM represents a spectrum of diseases, including acute otitis media (AOM), chronic suppurative otitis media (CSOM), and otitis media with effusion (OME) [1,2] (Table 1).
Table 1. Definition of otitis media.
Although OM can affect anyone, it is one of the most common infectious diseases in children, and is associated with significant medical resource use, medical visits, and antibiotic prescriptions. In developed countries, 80% of the children experience at least one episode of AOM by their third birthday. OM can occur at any age but is most common between 6 and 24 months of age. OM is a leading cause of medical visits worldwide, and its complications are an important cause of preventable hearing loss, particularly in developing countries. Consequently, the social burden is large [3,4,5,6,7]. Therefore, several measures have been taken to prevent and treat OM at an early stage.
The COVID-19 pandemic, which has lasted for more than two years, has changed daily lives. This has also changed the disease behavior. On 11 March 2020, the WHO declared COVID-19 a pandemic and introduced several measures to prevent its spread, including personal hygiene measures, such as mask-wearing and hand washing. Social distancing was also strongly recommended, and schools and businesses closed in many countries. These changes in daily life reduced close contact between people, which affected the behavior of people with many diseases. It was expected that the incidence of various infectious diseases would be greatly decreased. In particular, mask-wearing and social distancing were expected to significantly impact upper respiratory tract infections transmitted through breathing.
Since OM is mostly caused by the transmission of upper respiratory tract infections along the ear canal, if the incidence of upper respiratory tract infections is reduced, the incidence of OM will also decrease [2,8]. This is why facilities such as day care centers and kindergartens are risk factors for OM among infants and young children who are prone to OM [9]. However, there are no large-scale studies or guidelines for isolating children to prevent and treat OM. Social distancing due to COVID-19 has provided an unanticipated opportunity to examine the impact of social isolation on OM. Many studies have been conducted to scientifically establish this, and various conclusions have been derived. In this review, major studies and their significance are summarized, with the goal of organizing information to facilitate the prevention and treatment of OM.

2. The Epidemiology of OM Changed by COVID-19

The COVID-19 pandemic unexpectedly had many positive effects on OM, given the emphasis on personal hygiene and implementation of social distancing. We reviewed several studies, which are briefly summarized in Table 2, Table 3, Table 4 and Table 5. The observed changes can be broadly classified into the following four categories.

2.1. Decreased Incidence Rate of OM

A study that analyzed data obtained from children aged 0–17 in Massachusetts, USA, reported that social distancing (SD) reduced the incidence of many infectious diseases, including AOM. This study compared the incidence of infectious diseases between the pre- and post-SD periods. In the post-SD period, upper respiratory and respiratory infections, such as bronchiolitis, common cold, croup, influenza, pharyngitis, pneumonia, sinusitis, and AOM were drastically reduced. The authors speculated that the reduced prevalence of the diseases and the choice not to seek treatment when sick may have caused these outcomes [10].
In one study, the effect of COVID-19 lockdown on the onset of AOM was analyzed using data collected from six centers in Paris, France. This study, which included data from 871,543 children with pediatric department visits, reported that the incidence of AOM was reduced by more than 70% due to lockdown. In this study, infectious diseases such as the common cold, bronchiolitis, and acute gastroenteritis were also reduced by more than 70%, suggesting that lockdown had a strong effect on blocking infectious diseases in children. However, these results may not accurately reflect the actual incidence of infectious diseases in children, given the potential of caregivers to avoid going to the hospital for fear of contracting COVID-19 [11].
A study conducted by the otolaryngology departments of five tertiary referral centers in Italy investigated the effects of the COVID-19 pandemic on OME. The onset of OME in the pre- and post-pandemic periods was diagnosed and compared using tympanometry, tympanic findings, and pure tone audiometry. OME showed a sharp decline during the pandemic. However, there was no significant difference in the resolution and ventilation tube placement rates due to medical therapy in OME before and after the pandemic.
The reduction in the incidence of OME is explained by the reduction in the transmission of viruses, including respiratory syncytial virus, rhinovirus, adenovirus, bocavirus, influenza virus, parainfluenza virus, enterovirus, and human metapneumovirus, which are known causes of upper respiratory infections and AOM, due to restrictive anti-contagion measures, such as lockdown, continuous use of facial masks, SD, and reduction of social activities. Interestingly, during the pandemic, the incidence of OME decreased to a greater extent in children than in adults. The authors speculated that social isolation was stronger for children than for adults, because schools and kindergartens were completely closed [12].
In a prospective longitudinal study conducted at two hospitals in New York, USA, we investigated the effects of pandemic control measures on AOM and nasopharyngeal colonization in children aged 6–36 months. In this study, nasopharyngeal samples were collected from healthy children who underwent medical checkups at 6, 9, 12, 15, 18, 24, and 36 months and from children with AOM. During the pandemic, the proportion of children visiting AOM drastically decreased. Other respiratory diseases showed similar patterns. During the pandemic, there was a reduced detection of Haemophilus influenzae and Moraxella catarrhalis, but not Streptococcus pneumoniae, in nasopharyngeal samples from healthy children. However, there were no differences in the detection ratios of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae among children with AOM. As children usually acquire potentially pathogenic respiratory bacteria through close contact and fomite exposure, these findings are thought to be due to social distancing during the pandemic. Notably, the detection rate of oxacillin-resistant Streptococcus pneumoniae in nasopharyngeal samples increased during the pandemic, the authors speculated this to be related to bacterial virulence and capacity to colonize the nasopharynx with more limited inoculum from host to host in the absence of viral upper respiratory infection [13].
A German study used nationwide data to analyze the changes in the incidence rates of infectious diseases, injuries, chronic diseases, and mental and behavioral disorders during the COVID-19 pandemic in children aged 0–12 years. The database used in this study contained the medical records of almost all German children. During the COVID-19 period, there was a decrease in the incidence of almost all infectious diseases, as well as diseases of the middle ear and mastoid. This is due to social distancing, which was expected to have a particularly stressful effect on children, potentially leading to the deterioration of mental and physical health. However, a German study found that the incidence of injury, chronic diseases, and mental and behavioral disorders caused by social distancing decreased slightly. What is noteworthy here is that, although it was expected that being unable to visit and play with friends would cause increased social stress for children, this was not found in the studied population. The authors speculated that social distancing stress may offset by increasing family time and bonding. Another possibility is that these mental disorders might become a problem only after a certain amount of time post lockdown. Therefore, the authors argued that appropriate social distancing could be effective in reducing infectious diseases, such as diseases of the middle ear and mastoid, without significant side effects and that social distancing could be an appropriate treatment option for children with severe infectious diseases or weakened immune systems. This report could prove to be an important milestone for future treatment policies aimed at these infectious diseases [14] (Table 2).
Table 2. Summary of studies on incidence of OM during the COVID-19 pandemic.

2.2. Decreased Antibiotic Prescription for OM

A study of 405,688 people in the Netherlands found changes in the incidence of infectious diseases during the COVID-19 lockdown. Lockdown was found to reduce various infectious diseases, such as skin and gastrointestinal infections. Notably, the most prominently reduced infectious diseases were respiratory or ear infections. Among the various age groups studied in this work, the respiratory/ear infection frequency decreased most markedly in the 0–12-year-old group and increased slightly in the 41–65-year-old group. The total antibiotic prescription rate for respiratory/ear infections decreased from 21% to 13%. This is interpreted as the result of the lockdown due to COVID-19. This observation contrasted with reports from other countries, which found increases in the prescription rate of antibiotics, but the authors explained that this was due to differences in national health systems, etc. [19] (Table 3).
Table 3. Summary of studies on antibiotic prescriptions for OM during the COVID-19 pandemic.

2.3. Reduced Emergency Department Visits Due to OM

A study conducted at a tertiary care children’s hospital in Italy analyzed how emergency department (ED) visits changed during the COVID-19 period. The number of children who visited the ED and were hospitalized for various respiratory diseases decreased by 75.8% compared with the total number of children who visited the ED during the same period. Specifically, OM had 162 ED visits per 1000 people before COVID-19, but 26 per 1000 during the COVID-19 period. This indicates that social distancing can strongly block communicable diseases, although the authors cautioned that the differences could be more pronounced because of the reluctance to visit the hospital for fear of COVID-19 infection. According to the results of this study, while the rate of ED visits by critically ill children did not increase during the COVID-19 period, it would be reasonable to interpret that the disease itself decreased [21].
Other studies have reported similar results. A large-scale study based on records of ED visits to 27 children’s hospitals in the United States analyzed how children’s ED visitation behavior changed during the COVID-19 period. The rate of ED visits due to respiratory disease and OM was reduced by 70.0% and 75.1%, respectively [22]. In a similar study of 37 children’s hospitals in the United States, the authors used a predictive model to analyze how much the actual number of children visiting an ED decreased compared with the expected number of ED visits. The results showed a decrease in ED visits due to AOM during the COVID-19 period [23]. A study conducted at two hospitals in Finland also reported a COVID-19-associated decrease in ED visits to children due to AOM [24] (Table 4).
Table 4. Summary of studies on visitations to the emergency department for OM during the COVID-19 pandemic.

2.4. Reduced Complications of OM

In an Italian study, the effect of social restrictions on OME was examined. OME was evaluated by tympanometry in 932 children aged 6–12 years who visited a pediatric outpatient audiology clinic in Milan, Italy. The presence or absence of OME was diagnosed based on the tympanic membrane and type B tympanogram findings. The authors compared the onset of OME for consistent periods before and after social restriction and reported that social restriction sharply lowered the incidence of OME. The researchers observed that social restriction had the effect of blocking all infectious diseases and that OM decreased accordingly. In addition, the authors speculated that children with severe or incurable OME had more resolution after their social restriction, which could help inform the treatment of patients with OME in the future [16].
A study conducted in the Netherlands compared the incidence rates of OM and related complications between the COVID-19 pre-pandemic and pandemic periods among children aged 0–12 using a database in the Utrecht area. The study included 67,245 and 67,134 children during the COVID-19 pre-pandemic and pandemic periods, respectively. AOM, OME, and ear discharge decreased dramatically during the pandemic, and the incidence of acute mastoiditis and antibiotic prescription decreased accordingly. The authors mainly attributed the decrease in URI to lockdown and increased hand washing [15].
In a study conducted in Italy, 102 otitis-prone children (with a history of recurrent acute OM defined as ≥3 distinct episodes in 6 months or ≥4 in 12 months) were analyzed for changes in their OM status during the COVID-19 lockdown. The study found that during the lockdown period, 82% of children showed improvement in OM. Spontaneous tympanic membrane perforation episodes, otorrhea episodes, and systemic antibiotic treatment were significantly reduced. The authors speculated that this may have reflected the complete social isolation of the children rather than the avoidance of contact by otitis-prone children. The authors also proposed that lockdown-related improvements in air pollution may have played a role [27] (Table 5).
Table 5. Summary of studies on complications of OM during the COVID-19 pandemic.

2.5. Undetermined Whether OM Symptoms Worsened

OM can be caused by the transfer of pathogens from the nasopharynx to the middle ear. Viruses are one of the main causes of OM; they can be the sole cause of OM, or they can promote bacterial infection leading to OM. Viral infection adversely affects the middle ear in various ways, including immune disruption and reduced mucociliary function. The symptoms of OM have been reported to be more severe in patients infected with a virus [28,29]. Similarly, there are reports that OM symptoms are worse if OM develops in individuals with COVID-19. However, it is not yet clear whether SARS-CoV-2 (the virus that causes COVID-19) directly infects the middle ear and causes OM [30,31]. In another study, the symptoms of OM did not differ significantly between patients with and without COVID-19. In addition, another study observed no treatment failure, recurrence, or complications when OM occurred in COVID-19 patients [32]. Therefore, it is not yet known whether the symptoms of OM caused by SARS-CoV-2 infection are more severe or the prognosis is worse than those of OM caused by other viral infections.

3. Conclusions

The measures, including emphasis on personal hygiene and social distancing, put in place as a response to COVID-19, had many positive effects on OM. Due to the reduction of upper respiratory tract infections, the incidence of OM decreased drastically, as did the prescription of antibiotics. These changes resulted in a decrease in OM complications and the number of patients visiting the ED for OM.
Interestingly, strict personal hygiene management and social distancing lowered the severity of existing severe OM and complications. This finding suggests that quarantine measures alone, rather than conventional aggressive treatments, can prevent disease progression. Although more studies are needed in the future, the existing findings provide a useful reference for future OM treatment guidelines.
Conversely, some aspects of the measures implemented in response to COVID-19 may have negative effects on OM in the future. Personal protective measures may induce a kind of “immunity debt” in children. The acquired immunity, which must be naturally formed during social activities, is insufficient, which may lead to more frequent and serious development of upper respiratory tract infections and OM in the future [33]. In addition, due to social distancing, essential vaccinations have been delayed. This may increase the risk of outbreaks of various diseases that are preventable by vaccination. OM is one of the diseases affected by these delays, and it is necessary to quickly catch up with the essential vaccination schedule to supplement immunity [34,35].
It is difficult to definitively conclude how COVID-19 has affected OM, especially given that the world is not yet completely free from COVID-19. Based on these meaningful results, further studies are needed in the future.

Author Contributions

Conceptualization, S.-Y.C., Y.-S.C. and S.-G.Y.; methodology, S.-Y.C. and K.-H.P.; validation, D.-K.Y. and J.L.; formal analysis, Y.-J.L.; investigation, S.-H.K.; writing—original draft preparation, S.-Y.C.; writing—review and editing, S.-G.Y.; supervision, S.-S.K.; project administration, S.-G.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (NRF-2018R1A6A1A03025124). This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HV22C023300). The funders had no role in the study design, data collection, data analysis, data interpretation, or writing of the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Monasta, L.; Ronfani, L.; Marchetti, F.; Montico, M.; Brumatti, L.V.; Bavcar, A.; Grasso, D.; Barbiero, C.; Tamburlini, G. Burden of Disease Caused by Otitis Media: Systematic Review and Global Estimates. PLoS ONE 2012, 7, e36226. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  2. Rosenfeld, R.M.; Shin, J.J.; Schwartz, S.R.; Coggins, R.; Gagnon, L.; Hackell, J.; Hoelting, D.; Hunter, L.L.; Kummer, A.W.; Payne, S.; et al. Clinical Practice Guideline: Otitis Media with Effusion (Update). Otolaryngol. Neck Surg. 2016, 154, 201–214. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  3. Dubé, E.; De Wals, P.; Gilca, V.; Boulianne, N.; Ouakki, M.; Lavoie, F.; Bradet, R. Burden of acute otitis media on Canadian families. Can. Fam. Physician 2011, 57, 60–65. [Google Scholar] [PubMed]
  4. Dubé, E.; De Wals, P.; Ouakki, M. Quality of life of children and their caregivers during an AOM episode: Development and use of a telephone questionnaire. Health Qual. Life Outcomes 2010, 8, 75. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  5. Hansen, M.P.; Howlett, J.; Del Mar, C.; Hoffmann, T.C. Parents’ beliefs and knowledge about the management of acute otitis media: A qualitative study. BMC Fam. Pract. 2015, 16, 82. [Google Scholar] [CrossRef] [Scilit]
  6. Qureishi, A.; Lee, Y.; Belfield, K.; Birchall, J.P.; Daniel, M. Update on otitis media–prevention and treatment. Infect. Drug Resist. 2014, 7, 15. [Google Scholar]
  7. Vergison, A.; Dagan, R.; Arguedas, A.; Bonhoeffer, J.; Cohen, R.; Dhooge, I.; Hoberman, A.; Liese, J.; Marchisio, P.G.; Palmu, A.A.; et al. Otitis media and its consequences: Beyond the earache. Lancet Infect. Dis. 2010, 10, 195–203. [Google Scholar] [CrossRef] [Scilit]
  8. Chonmaitree, T.; Revai, K.; Grady, J.J.; Clos, A.; Patel, J.A.; Nair, S.; Fan, J.; Henrickson, K.J. Viral Upper Respiratory Tract Infection and Otitis Media Complication in Young Children. Clin. Infect. Dis. 2008, 46, 815–823. [Google Scholar] [CrossRef] [Scilit]
  9. Todberg, T.; Koch, A.; Andersson, M.; Olsen, S.F.; Lous, J.; Homøe, P. Incidence of Otitis Media in a Contemporary Danish National Birth Cohort. PLoS ONE 2014, 9, e111732. [Google Scholar] [CrossRef] [Scilit]
  10. Hatoun, J.; Correa, E.T.; Donahue, S.M.A.; Vernacchio, L. Social Distancing for COVID-19 and Diagnoses of Other Infectious Diseases in Children. Pediatrics 2020, 146, e2020006460. [Google Scholar] [CrossRef] [Scilit]
  11. Angoulvant, F.; Ouldali, N.; Yang, D.D.; Filser, M.; Gajdos, V.; Rybak, A.; Guedj, R.; Soussan-Banini, V.; Basmaci, R.; Lefevre-Utile, A.; et al. Coronavirus Disease 2019 Pandemic: Impact Caused by School Closure and National Lockdown on Pediatric Visits and Admissions for Viral and Nonviral Infections—A Time Series Analysis. Clin. Infect. Dis. 2021, 72, 319–322. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  12. Iannella, G.; Magliulo, G.; Lechien, J.R.; Maniaci, A.; Perrone, T.; Frasconi, P.C.; De Vito, A.; Martone, C.; Ferlito, S.; Cocuzza, S.; et al. Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: A multicenter study. Eur. Arch. Oto-Rhino-Laryngol. 2021, 279, 2383–2389. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  13. Kaur, R.; Schulz, S.; Fuji, N.; Pichichero, M. COVID-19 Pandemic Impact on Respiratory Infectious Diseases in Primary Care Practice in Children. Front. Pediatr. 2021, 9, 909. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  14. Barschkett, M.; Koletzko, B.; Spiess, C.K. COVID-19 Associated Contact Restrictions in Germany: Marked Decline in Children’s Outpatient Visits for Infectious Diseases without Increasing Visits for Mental Health Disorders. Children 2021, 8, 728. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  15. Hullegie, S.; Schilder, A.G.M.; Marchisio, P.; de Sévaux, J.L.H.; van der Velden, A.W.; van de Pol, A.C.; Boeijen, J.A.; Platteel, T.N.; Torretta, S.; Damoiseaux, R.A.M.J.; et al. A Strong Decline in the Incidence of Childhood Otitis Media During the COVID-19 Pandemic in the Netherlands. Front. Cell. Infect. Microbiol. 2021, 11, 768377. [Google Scholar] [CrossRef] [Scilit]
  16. Alde, M.; Di Berardino, F.; Marchisio, P.; Cantarella, G.; Ambrosetti, U.; Consonni, D.; Zanetti, D. Effects of COVID-19 Lockdown on Otitis Media With Effusion in Children: Future Therapeutic Implications. Otolaryngol.–Head Neck Surg. 2021, 165, 710–715. [Google Scholar] [CrossRef] [Scilit]
  17. Rohe, A.M.; Kostev, K.; Sesterhenn, A.M. Impact of the COVID-19 pandemic on consultations and diagnosis in ENT practices in Germany. Laryngo-Rhino-Otologie 2021, 101, 414–418. [Google Scholar]
  18. Quraishi, N.; Ray, M.; Srivastava, R.; Ray, J.; Quraishi, M.S. A multicentre retrospective cohort study on COVID-19-related physical interventions and adult hospital admissions for ENT infections. Eur. Arch. Oto-Rhino-Laryngol. 2022, 279, 2671–2678. [Google Scholar] [CrossRef] [Scilit]
  19. van de Pol, A.C.; Boeijen, J.A.; Venekamp, R.P.; Platteel, T.; Damoiseaux, R.A.; Kortekaas, M.F.; van der Velden, A.W. Impact of the COVID-19 pandemic on antibiotic prescribing for common infections in the Netherlands: A primary care-based observational cohort study. Antibiotics 2021, 10, 196. [Google Scholar] [CrossRef] [Scilit]
  20. Katz, S.E.; Spencer, H.; Zhang, M.; Banerjee, R. Impact of the COVID-19 Pandemic on Infectious Diagnoses and Antibiotic Use in Pediatric Ambulatory Practices. J. Pediatr. Infect. Dis. Soc. 2020, 10, 62–64. [Google Scholar] [CrossRef] [Scilit]
  21. Rotulo, G.A.; Percivale, B.; Molteni, M.; Naim, A.; Brisca, G.; Piccotti, E.; Castagnola, E. The impact of COVID-19 lockdown on infectious diseases epidemiology: The experience of a tertiary Italian Pediatric Emergency Department. Am. J. Emerg. Med. 2021, 43, 115–117. [Google Scholar] [CrossRef] [Scilit]
  22. Dong, Y.; Mo, X.I.; Hu, Y.; Qi, X.; Jiang, F.; Jiang, Z.; Tong, S. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics 2020, 145, e20200702. [Google Scholar] [CrossRef] [Scilit]
  23. Ramgopal, S.; Pelletier, J.H.; Rakkar, J.; Horvat, C.M. Forecast modeling to identify changes in pediatric emergency department utilization during the COVID-19 pandemic. Am. J. Emerg. Med. 2021, 49, 142–147. [Google Scholar] [CrossRef] [Scilit]
  24. Kuitunen, I.; Artama, M.; Mäkelä, L.; Backman, K.; Heiskanen-Kosma, T.; Renko, M. Effect of Social Distancing Due to the COVID-19 Pandemic on the Incidence of Viral Respiratory Tract Infections in Children in Finland During Early 2020. Pediatr. Infect. Dis. J. 2020, 39, e423–e427. [Google Scholar] [CrossRef] [Scilit]
  25. DeLaroche, A.M.; Rodean, J.; Aronson, P.L.; Fleegler, E.W.; Florin, T.A.; Goyal, M.; Hirsch, A.W.; Jain, S.; Kornblith, A.E.; Sills, M.R.; et al. Pediatric Emergency Department Visits at US Children’s Hospitals During the COVID-19 Pandemic. Pediatrics 2021, 147, e2020039628. [Google Scholar] [CrossRef] [Scilit]
  26. Bucher, S.; Neumann, A.S.; Meerwein, C.M.; Holzmann, D.; Soyka, M.B. Reduction of otorhinolaryngological consultations due to the COVID-19 lockdown and its impact on disease progression. Swiss Med. Wkly. 2021, 151, w30068. [Google Scholar]
  27. Torretta, S.; Capaccio, P.; Coro, I.; Bosis, S.; Pace, M.E.; Bosi, P.; Pignataro, L.; Marchisio, P. Incidental lowering of otitis-media complaints in otitis-prone children during COVID-19 pandemic: Not all evil comes to hurt. Eur. J. Pediatr. 2021, 180, 649–652. [Google Scholar] [CrossRef] [Scilit]
  28. Buchman, A.C.; Brinson, G.M. Viral otitis media. Curr. Allergy Asthma Rep. 2003, 3, 335–340. [Google Scholar] [CrossRef] [Scilit]
  29. Nokso-Koivisto, J.; Marom, T.; Chonmaitree, T. Importance of viruses in acute otitis media. Curr. Opin. Pediatr. 2015, 27, 110–115. [Google Scholar] [CrossRef] [Scilit]
  30. Fidan, V. New type of corona virus induced acute otitis media in adult. Am. J. Otolaryngol. 2020, 41, 102487. [Google Scholar] [CrossRef] [Scilit]
  31. Raad, N.; Ghorbani, J.; Mikaniki, N.; Haseli, S.; Karimi-Galougahi, M. Otitis media in coronavirus disease 2019: A case series. J. Laryngol. Otol. 2021, 135, 10–13. [Google Scholar] [CrossRef] [Scilit]
  32. Frost, H.M.; Sebastian, T.; Keith, A.; Kurtz, M.; Dominguez, S.R.; Parker, S.K.; Jenkins, T.C. COVID-19 and Acute Otitis Media in Children: A Case Series. J. Prim. Care Community Health 2022, 13, 1–6. [Google Scholar] [CrossRef] [PubMed]
  33. Cohen, R.; Ashman, M.; Taha, M.-K.; Varon, E.; Angoulvant, F.; Levy, C.; Ryback, A.; Ouldali, N.; Guiso, N.; Grimprel, E. Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? Infect. Dis. Now 2021, 51, 418–423. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  34. Santoli, J.M.; Lindley, M.C.; DeSilva, M.B.; Kharbanda, E.O.; Daley, M.F.; Galloway, L.; Gee, J.; Glover, M.; Herring, B.; Kang, Y.; et al. Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration—United States, 2020. MMWR. Morb. Mortal. Wkly. Rep. 2020, 69, 591–593. [Google Scholar] [CrossRef] [Scilit]
  35. Cohen, R.; Martinot, A.; Gaudelus, J.; Subtil, D.; Stahl, J.-P.; Pujol, P.; Picquet, V.; Lepetit, H.; Longfier, L.; Leboucher, B. Infant mandatory vaccinations: Confirmation of a positive impact. Médecine Mal. Infect. 2020, 50, 74–77. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.